Delivery Order SPE2DB20D6036-SPE2DB24FC8JK
Award Date
3/29/24
Potential Completion Date
4/1/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $1,086.12, is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, a specialty medication. The contract has a firm fixed price pricing type and a completion date of January 9, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
The U.S. Department of Defense's (DoD) Defense Logistics Agency (DLA) Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of pharmaceutical products, including the supply of 4565140856 ATOMOXETINE HCL 40 MG CAPSULE 30S. The contract, with a ceiling value of $3,577.19, has an ultimate completion date of July 16, 2024 and was awarded on July 15, 2024. This order is part of a larger Indefinite...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,600.04 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide ATOMOXETINE HCL 25 MG CAPSULE 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This is a delivery order (SPE2DB20D3104|SPE2DB24FV9B7) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $1,241.49, is for the delivery of ATOMOXETINE HCL 60 MG CAPSULE 30S, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for AmerisourceBergen to provide a...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,723.67 award is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, a pharmaceutical product, with a completion date of February 12, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Atomoxetine HCL 40 mg capsules. The firm-fixed-price contract, which does not have a set-aside designation, has a ceiling value of $1,891.58 and an ultimate completion date of September 30, 2024. AmerisourceBergen, through its Corporate Office Division, is a key contractor for providing a wide range of prescription medications,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,242.67 firm-fixed-price delivery order is for the supply of ATOMOXETINE HCL 10 MG CAPSULES, with a completion date of November 8, 2024. The award is not designated as a set-aside contract.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,315.00 firm fixed-price delivery order is for the supply of ATOMOXETINE HCL 18 30S, a pharmaceutical product. The contract has an ultimate completion date of November 14, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,448,424 units of ATOMOXETINE HCL 25 MG CAPSULE 30S. The $1,321.10 contract runs from January 25, 2024 to January 26, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product to the DLA Troop Support Medical facilities in Conshohocken,...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of atomoxetine hydrochloride 25 mg capsules, with a potential value of $1,342.24 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was...